% 0期刊文章% @ 1438 - 8871 V %我JMIR出版物I卡塔尔世界杯8强波胆分析nc . % 17% 1% N P e6 % T虚拟支持自我管理干预抗逆转录病毒治疗的艾滋病毒感染者%象牙海岸,何塞% Godin,加斯顿% Ramirez-Garcia,皮拉尔%一个卷轴,吉纳维芙%波旁,安妮% Gueheneuc, Yann-Gael % Tremblay,塞西尔%奥蒂斯,乔安妮% +研究中心中心的医院因为学校蒙特利尔,850圣丹尼斯街,旅游St-Antoine,三楼,门s03 - 424, QC,加拿大,蒙特利尔1 514 890 8000 ext 15536, jose.cote@umontreal.ca %K坚持%K抗逆转录病毒治疗，高活性%K HIV感染患者%K人类免疫缺陷病毒%K护理%K护理信息学%K网络干预%D 2015 %7 2015年6月1日%9原始论文%J J医学互联网Res %G英文%X背景:携带人类免疫缺陷病毒(HIV)生活需要长期的医疗随访，特别是关于抗逆转录病毒治疗(ART)管理。利用信息和通信技术(ICT)提供的巨大可能性，我们开发了一种虚拟护理干预(VIH-TAVIE)，旨在使艾滋病毒患者能够以最佳方式管理他们的抗逆转录病毒治疗和他们的症状。信通技术干预措施在整个艾滋病毒患者护理连续体中具有巨大的前景，但需要进一步研究以适当评估其有效性。目的:本研究的目的是比较两种类型的随访——传统的和虚拟的——在促进HIV患者抗逆转录病毒治疗依从性方面的有效性。方法:采用准实验方法。参与研究的179名艾滋病患者接受了至少6个月的抗逆转录病毒治疗，其中99人在一个提供虚拟随访的地点被招募，80人在另一个只提供传统随访的地点被招募。主要结局是药物依从性，次要结局是以下认知和情感变量:自我效能、对药物摄入的态度、与症状相关的不适、压力和社会支持。在基线(T0)、3 (T3)和6个月(T6)后通过自我填写问卷进行评估。结果:参与者平均携带HIV病毒14年，接受ART治疗11年。 The groups were highly heterogeneous, differing on a number of sociodemographic dimensions: education, income, marital status, employment status, and living arrangements. Adherence at baseline was high, reaching 80% (59/74) in the traditional follow-up group and 84% (81/97) in the virtual follow-up group. A generalized estimating equations (GEE) analysis was run, controlling for sociodemographic characteristics at baseline. A time effect was detected indicating that both groups improved in adherence over time but did not differ in this regard. Improvement at 6 months was significantly greater than at 3 months in both groups. Analysis of variance revealed no significant group-by-time interaction effect on any of the secondary outcomes. A time effect was observed for the two kinds of follow-ups; both groups improved on symptom-related discomfort and social support. Conclusions: Results showed that both interventions improved adherence to ART. Thus, the two kinds of follow-up can be used to promote treatment adherence among HIV patients on ART. %M 25563775 %R 10.2196/jmir.3264 %U //www.mybigtv.com/2015/1/e6/ %U https://doi.org/10.2196/jmir.3264 %U http://www.ncbi.nlm.nih.gov/pubmed/25563775